title: Will integrin inhibitors have proangiogenic effects in the clinic?
authors: Michael
authors: M
authors: Weller
authors: David
authors: D
authors: Reardon
authors: Burt
authors: B
authors: Nabors
authors: Roger
authors: R
authors: Stupp
mesh_terms: D000818:Animals; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D016023:Integrins / Q000037:antagonists & inhibitors*; D009389:Neovascularization, Pathologic / Q000139:chemically induced*; D012910:Snake Venoms / Q000009:adverse effects*
chemical_list: D016023:Integrins; D012910:Snake Venoms; C422910:Cilengitide